Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma

Figure 5

Subgroup survival analysis. (a) Risk score-based survival analysis in patients with . (b) Risk score-based survival analysis in patients with . (c) Risk score-based survival analysis in female patients. (d) Risk score-based survival analysis in male patients. (e) Risk score-based survival analysis in patients with stages I and II. (f) Risk score-based survival analysis in patients with stages III and IV. (g) Risk score-based survival analysis in patients with G1-2. (h) Risk score-based survival analysis in patients with G3-4. (i) Risk score-based survival analysis in patients with T1-2. (j) Risk score-based survival analysis in patients with T3-4. (k) Risk score-based survival analysis in patients with N0. (l) Risk score-based survival analysis in patients with N1. (m) Risk score-based survival analysis in patients with M0. (n) Risk score-based survival analysis in patients with M1.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)